Comprehensive Epilepsy Program receives highest national accreditation rating
Our Comprehensive Epilepsy Program has been accredited as a level 4 center for adult and pediatric epilepsy, the highest designation awarded, by the National Association of Epilepsy Centers (NAEC). The program is a leader in the surgical management of refractory epilepsy, with a wide array of services that includes a new 11-bed monitoring unit scheduled to open at the end of the year. As a level 4 center, the program provides more complex forms of intensive neurodiagnostic monitoring, as well as more extensive medical neuropsychological and psychosocial treatment. Level 4 centers also offer complete evaluation for epilepsy surgery and a broad range of surgical procedures, such as minimally invasive laser surgery and devices such as responsive neurostimulation, deep brain stimulation and vagal nerve stimulation.
Brooks-Kayal named Gabor Presidential Chair
Department of Neurology Chair Amy Brooks-Kayal, M.D., F.A.A.N., F.A.N.A., F.A.E.S., has been inducted as inaugural holder of the Andrew John Gabor, M.D., Ph.D. Presidential Chair. Brooks-Kayal is an internationally recognized neurologist, epilepsy expert, and research leader on novel seizure therapies, who has served as president of the American Epilepsy Society and held other national roles.
New gene causing severe neurodevelopmental delays
An international team of researchers led by UC Davis geneticists has discovered a new gene implicated in a neurodevelopmental condition called DPH5-related diphthamide-deficiency syndrome. The syndrome is caused by DPH5 gene variants that may lead to embryonic death or profound neurodevelopmental delays. UC Davis led the project with collaborations from Germany, Saudi Arabia, Sweden, Massachusetts and California, with findings published in Genetics in Medicine.
